Clinical Research Directory
Browse clinical research sites, groups, and studies.
Algorithm-based Management to Reduce the Recurrence of GI Bleeding and Severe Epistaxis in Von Willebrand Disease
Sponsor: University Hospital, Lille
Summary
WILL MANAGE is a prospective multicenter controlled open label randomized trial comparing an algorithm-based multidisciplinary management to a standard of care to reduce the incidence of bleeding (GI bleeding or severe epistaxis) recurrence in von Willebrand disease.
Official title: Algorithm-based Management to Reduce the Recurrence of Gastrointestinal Bleeding and Severe Epistaxis in Von Willebrand Disease: WILL-MANAGE Trial
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
66
Start Date
2025-04
Completion Date
2034-12-06
Last Updated
2025-03-13
Healthy Volunteers
No
Conditions
Interventions
Optimized management
systematic gastrointestinal and nasal endoscopic exploration, local endoscopic treatment whenever applicable,prophylaxis with stepwise dose escalation of VWF concentrate and use of antiangiogenic drugs in patients with severe GI angiodysplasia-related bleeding
Standard of care management
Standard of care management
Locations (17)
CHU Lille
Lille, Nord, France
CHU Tours
Tours, Tours, France
CHU Amiens
Amiens, France
CHRU Brest
Brest, France
Hôpital cardiologique Louis Pradel
Bron, France
CHU Caen
Caen, France
CH Chambery
Chambéry, France
CHU Clermont-Ferrand
Clermont-Ferrand, France
CHU Dijon
Dijon, France
AP-HP Hôpital Kremlin Bicetre
Le Kremlin-Bicêtre, France
AP-HM Hôpital Timone
Marseille, France
CHU Montpellier
Montpellier, France
CHU Nantes
Nantes, France
CHU Rennes
Rennes, France
CHU Rouen
Rouen, France
CHU Strasbourg
Strasbourg, France
CHU Toulouse
Toulouse, France